For over 30 years, my passion has been centered on turning complex life sciences challenges into actionable insights that empower stakeholders—researchers, regulators, and payers—to make smarter, faster decisions that truly impact patient care. I specialize in leveraging advanced analytics, AI, and evidence generation to accelerate drug development, reduce trial costs, and improve patient outcomes. At Medidata, I led the commercialization of synthetic control arm and digital health solutions that have saved patient lives, company costs and sped up medicines to market. I look forward to the next chapters of industry transformation.
Attendees will gain a deep understanding of how AI, machine learning, and automation are revolutionizing pharmacovigilance by streamlining case processing, enhancing signal detection, and driving operational efficiency. They will explore real-world applications, innovative tools, and forward-looking strategies to build trust in AI and future-proof safety operations across the drug development lifecycle.
Attendees will gain a deep understanding of how AI, machine learning, and automation are revolutionizing pharmacovigilance by streamlining case processing, enhancing signal detection, and driving operational efficiency. They will explore real-world applications, innovative tools, and forward-looking strategies to build trust in AI and future-proof safety operations across the drug development lifecycle.